- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/18 - Halogen atoms or nitro radicals
Patent holdings for IPC class C07D 215/18
Total number of patents in this class: 299
10-year publication summary
|
17
|
13
|
23
|
30
|
17
|
17
|
11
|
13
|
10
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
18 |
| IntelGenx Corp. | 72 |
10 |
| Merck Patent GmbH | 5831 |
8 |
| Gilead Sciences, Inc. | 2036 |
8 |
| CHDI Foundation, Inc. | 108 |
7 |
| Synthon BV | 317 |
5 |
| F. Hoffmann-La Roche AG | 7925 |
4 |
| Bayer Cropscience AG | 2035 |
4 |
| Akaal Pharma Pty Ltd. | 11 |
4 |
| The Regents of the University of California | 19918 |
3 |
| Janssen Pharmaceutica N.V. | 3392 |
3 |
| Monsanto Technology LLC | 8284 |
3 |
| The Regents of the University of Michigan | 4698 |
3 |
| Dr. Reddy's Laboratories, Inc. | 179 |
3 |
| Dr. Reddy's Laboratories Limited | 550 |
3 |
| Esteve Quimica, S.A. | 27 |
3 |
| Hanmi Pharm. Co., Ltd. | 570 |
3 |
| Nippon Soda Co., Ltd. | 895 |
3 |
| Aptuit Laurus Private Limited | 10 |
3 |
| Université Paris-saclay | 535 |
3 |
| Other owners | 198 |